title: Pharmacokinetics of theophylline and its metabolites during acute renal failure. A case report.
abstract: After unsuccessful therapy with salbutamol syrup and inhaled terbutaline a 3-year-old boy with an acute exacerbation of asthma was treated with nebulised salbutamol (albuterol), intravenous aminophylline and hydrocortisone. His condition continued to deteriorate and he required artificial ventilation. Subsequently, he became anuric, with liver dysfunction, nonspecific encephalopathy and limb tremor. Peritoneal dialysis was started. Plasma theophylline concentrations were monitored and maintained in the therapeutic or subtherapeutic range. Despite this, he was hyper-reflexic with limb tremor. Excessively high plasma concentrations of the principal theophylline metabolite, 1,3-dimethyluric acid, were found [maximum 92 mg/L (470 mumol/L)], which cleared only with the return of normal renal function. Plasma concentration monitoring of drugs other than theophylline was not performed. After the patient recovered, a pharmacokinetic study demonstrated that normal methylxanthine metabolism was re-established. Pharmacokinetic analysis indicated that the undue accumulation of the metabolites was a result of an inability to clear these compounds. Thus, pharmacologically and toxicologically active metabolites of theophylline may accumulate in anuric patients on peritoneal dialysis, producing clinical symptoms of toxicity. However, in the present case the possible role of metabolites of other drugs cannot be definitely excluded.
authors.affiliation: Queen Elizabeth Hospital for Children, London, England.
authors.forename: T E
authors.initials: TE
authors.lastname: Leakey
authors.forename: A C
authors.initials: AC
authors.lastname: Elias-Jones
authors.forename: P E
authors.initials: PE
authors.lastname: Coates
authors.forename: K J
authors.initials: KJ
authors.lastname: Smith
mesh_terms: D058186:Acute Kidney Injury / Q000378:metabolism* / Q000628:therapy; D001249:Asthma / Q000188:drug therapy; D002675:Child, Preschool; D006801:Humans; D008297:Male; D008657:Metabolic Clearance Rate; D010530:Peritoneal Dialysis; D013806:Theophylline / Q000009:adverse effects / Q000378:metabolism / Q000493:pharmacokinetics*; D014527:Uric Acid / Q000031:analogs & derivatives / Q000097:blood
chemical_list: D014527:Uric Acid; D013806:Theophylline; C031274:1,3-dimethyluric acid